IOLAB.SITE CD Phacoemulsification Module
510(k) K944993
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK944993 | Date12 Oct 1995 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- HQC
- Device Class
- Class II
- Regulation
- 21 CFR Part 886.4670
- Advisory Committee
- Ophthalmic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
This device is a Phacoemulsification Unit (OpenFDA classification: Unit, Phacofragmentation), designed for cataract surgery. It employs ultrasonic energy to emulsify and aspirate the lens nucleus, facilitating its removal and replacement with an intraocular lens (IOL). The system integrates with the IOLAB.SITE platform to perform precise phacoemulsification procedures in ophthalmic settings.
The IOLAB.SITE CD Phacoemulsification Module is intended for single-use in sterile surgical environments, adhering to FDA 510(k) clearance (K944993) under the HQC product code. It is classified as a Class II medical device and is regulated under FDA regulation number 886.4670. Compatible with MRI-safe surgical settings, the module is supplied as part of a modular ophthalmic system and requires proper storage to maintain sterility and functionality.
Other devices from Chiron Vision Corp.
Questions
AI-generated answers, 19 Sep 2026
What is the primary purpose of the IOLAB.SITE CD Phacoemulsification Module in cataract surgery?
The IOLAB.SITE CD Phacoemulsification Module is designed to emulsify and aspirate the lens nucleus during cataract surgery using ultrasonic energy. This process facilitates the removal of the clouded lens, allowing it to be replaced with an intraocular lens (IOL). It integrates with the IOLAB.SITE platform to perform precise phacoemulsification procedures in ophthalmic settings.
Is the IOLAB.SITE CD Phacoemulsification Module intended for single-use or reusable applications?
The device is explicitly intended for single-use in sterile surgical environments. This design ensures patient safety and maintains sterility, as reuse could compromise its integrity and introduce infection risks.
What regulatory pathway was followed for FDA clearance of this device, and what classification does it hold?
The IOLAB.SITE CD Phacoemulsification Module received FDA 510(k) clearance (K944993) under the HQC product code, following a Traditional 510(k) review. It is classified as a Class II medical device and is regulated under FDA regulation number 886.4670, indicating it requires compliance with specific performance standards and labeling requirements.
Can this module be used in MRI-safe surgical environments, and how should it be stored to maintain functionality?
Yes, the IOLAB.SITE CD Phacoemulsification Module is compatible with MRI-safe surgical settings. To maintain sterility and functionality, it must be stored according to manufacturer guidelines—typically in a sealed, sterile packaging until use, away from extreme temperatures, moisture, or contamination.
Are there multiple models or sizes available for this phacoemulsification module, and how would I identify the correct one for my procedure?
The provided data lists multiple FEI numbers (e.g., 1000120314, 3006695864), which likely correspond to different model variants or configurations of the IOLAB.SITE CD Phacoemulsification Module. These variations may cater to specific surgical needs (e.g., power settings, probe compatibility, or procedural adjustments). To determine the correct model, consult the manufacturer’s documentation or a surgical specialist, as selection depends on factors like patient anatomy, surgeon preference, and procedural complexity.